Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years

被引:95
作者
Liu, Yudong [1 ]
Wang, Hui [1 ]
Chen, Minjun [1 ]
Sun, Ziyong [2 ]
Zhao, Renzhen [3 ]
Zhang, Li [4 ]
Wang, Huiyun [5 ]
Zhang, Hong [6 ]
Wang, Luoping [7 ]
Chu, Yunzhuo [8 ]
Liu, Yong [9 ]
Ni, Yuxing [10 ]
机构
[1] Chinese Acad Med Sci, Dept Clin Lab, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China
[3] Shenzhen Childrens Hosp, Shenzhen 518026, Peoples R China
[4] Chengdu Childrens Hosp, Chengdu 610014, Peoples R China
[5] Nanjing Childrens Hosp, Nanjing 210008, Peoples R China
[6] Shanghai Childrens Hosp, Shanghai 200032, Peoples R China
[7] Capital Inst Pediat, Beying 100020, Peoples R China
[8] First Hosp China Med Univ, Shenyang 110001, Peoples R China
[9] Shengjing Hosp China Med Univ, Shenyang 110001, Peoples R China
[10] Shanghai Ruijin Hosp, Shanghai 200025, Peoples R China
关键词
Streptococcus pneumoniae; antimicrobial resistance; serotypes; serogroups; pneumococcal glycoconjugate vaccine;
D O I
10.1016/j.diagmicrobio.2008.02.004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study examined the epidemiology, antibiotic susceptibility, and serotype distribution of Streptococcus pneumoniae associated with invasive and noninvasive pneumococcal disease in children in China. A total of 451 clinical isolates from children (age, <5 years) were collected from 8 cities from January 2005 to December 2006, including 31 isolated from invasive disease. In vitro susceptibility to 14 antimicrobial agents was determined by the agar dilution method. Among all isolates tested, 64.3% were resistant to penicillin, and for invasive isolates, the resistance rate was 55.2%. Isolates from Wuhan and Nanjing showed the highest prevalence of penicillin resistance (89.6% and 85%), followed by those from Shenzhen (72.4%) and Chengdu (56.7%). Multidrug resistance rates to tetracycline, erythromycin, and clindamycin reached 90%. The 6 most common serotypes were 19F, 19A, 14, 613, 23F, and 15. These accounted for 80.7% of the isolates. Resistance to penicillin varied among the 6 leading serotypes, ranging from 20% in serotype 15 to 87.3% in serotype 19F. Each of the 8 cities had different serotype distribution. The potential coverage by 7-, 10-, and 13-valent pneumococcal conjugate vaccine were 63.6%, 64.8%, and 79.6%, respectively. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:256 / 263
页数:8
相关论文
共 27 条
[1]  
[Anonymous], 2000, MMWR Recomm Rep, V49, P1
[2]  
[Anonymous], [No title captured]
[3]   Resistance among Streptococcus pneumoniae:: Implications for drug selection [J].
Appelbaum, PC .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) :1613-1620
[4]   Streptococcus pneumoniae colonisation:: the key to pneumococcal disease [J].
Bogaert, D ;
de Groot, R ;
Hermans, PWM .
LANCET INFECTIOUS DISEASES, 2004, 4 (03) :144-154
[5]   Antibacterial agents in pediatrics [J].
Bowlware, KL ;
Stull, T .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2004, 18 (03) :513-+
[6]  
*CLIN LAB STAND I, 2006, M100S16 CLSI
[7]   GENETIC-ANALYSIS OF CLINICAL ISOLATES OF STREPTOCOCCUS-PNEUMONIAE WITH HIGH-LEVEL RESISTANCE TO EXPANDED-SPECTRUM CEPHALOSPORINS [J].
COFFEY, TJ ;
DANIELS, M ;
MCDOUGAL, LK ;
DOWSON, CG ;
TENOVER, FC ;
SPRATT, BG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1306-1313
[8]   Current concepts: The prevention of pneumococcal disease in children. [J].
Giebink, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (16) :1177-1183
[9]   Streptococcus pneunoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain (1979-1997) [J].
Granizo, JJ ;
Aguilar, L ;
Casal, J ;
García-Rey, C ;
Dal-Ré, R ;
Baquero, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) :767-773
[10]   Which pneumococcal serogroups cause the most invasive disease: Implications for conjugate vaccine formulation and use, part I [J].
Hausdorff, WP ;
Bryant, J ;
Paradiso, PR ;
Siber, GR .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (01) :100-121